Skip to main content
Stonvex
Loading…
Home
Markets
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search...
Cmd K
Search...
Cmd K
← Back to rankings
AMRX
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
52w high -19.5%
AMRX
Amneal Pharmaceuticals, Inc. Class A Common Stock
☁️ News word cloud
Top words across the last 50 articles for this ticker.
amneal
nasdaq
pharmaceuticals
market
billion
after
global
treatment
estimates
expected
drug
results
stocks
gained
rose
grow
price
higher
climbed
healthcare
StonvexStonvexStonvexStonvex